GCM
ASND icon

Ghisallo Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Ghisallo Capital Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$747K – 117
2024
Q3 		$747K Buy
+5,000
New +$675K 0.04% 133

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ghisallo Capital Management's ASND Position: Q4 2024 in Review

Ghisallo Capital Management sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 5,000 shares — an estimated $747K sold.

Ghisallo Capital Management first reported a position in ASND in Q3 2024 and held it in 1 quarter. The position peaked at $747K in Q3 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

  • Ghisallo Capital Management reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
  • Ghisallo Capital Management sold 5,000 Ascendis Pharma A/S shares in Q4 2024, an estimated $747K.
  • Ghisallo Capital Management first reported a position in Ascendis Pharma A/S in Q3 2024 and held it in 1 quarter.
  • Ghisallo Capital Management's Ascendis Pharma A/S position peaked at $747K in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Ghisallo Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.